News

TRINOVA-1 signals new direction in ovarian cancer

Publish date: October 4, 2013

 

AT THE EUROPEAN CANCER CONGRESS 2013

pwendling@frontlinemedcom.com

Pages

Recommended Reading

Switching nonadherent to denosumab improved bone density
MDedge ObGyn
Metronidazole needed for complete pelvic inflammatory disease coverage
MDedge ObGyn
Vitrification efficiently preserves oocytes, embryos
MDedge ObGyn
High-dose intravaginal metronidazole/miconazole may help BV
MDedge ObGyn
M. genitalium demands new STI treatment strategy
MDedge ObGyn
Biweekly 5-fluorouracil cream beat back cervical neoplasia
MDedge ObGyn
New Candida species isolated in U.S.
MDedge ObGyn
Catheter UTIs cleared with old-fashioned oxychlorosene flush
MDedge ObGyn
New option for treating menopausal vasomotor symptoms receives FDA approval
MDedge ObGyn
Ospemifene for dyspareunia in postmenopausal women is well tolerated
MDedge ObGyn